| Otonomy, Inc. |
1.68 |
| NextCure, Inc. |
1.03 |
| Cogent Biosciences, Inc. |
0.5 |
| Jounce Therapeutics, Inc. |
0.49 |
| Odonate Therapeutics, Inc. |
0.48 |
| ImmunoGen |
0.41 |
| Aclaris Therapeutics, Inc. |
0.31 |
| Dicerna Pharmaceuticals, Inc. |
0.3 |
| MacroGenics, Inc. |
0.29 |
| Morphic Holding, Inc. |
0.28 |
| Relmada Therapeutics, Inc. |
0.27 |
| Vericel Corporation |
0.26 |
| Veracyte, Inc. |
0.21 |
| Mersana Therapeutics, Inc. |
0.17 |
| Insmed Incorporated |
0.17 |
| Affimed |
0.17 |
| Kala Pharmaceuticals, Inc. |
0.16 |
| Aptinyx Inc. |
0.16 |
| Intra-Cellular Therapies, Inc. |
0.14 |
| Scholar Rock Holding Corporation |
0.11 |
